Mesoblast (MESO) Return on Sales (2016 - 2023)

Mesoblast has disclosed Return on Sales across 8 years of filings, most recently posting 0.04% for Q2 2023.

• Return on Sales for Q2 2023 came in at 0.04%, up 11.0% year-over-year; the trailing twelve-month figure through Mar 2023 was 0.09% (up 1.0% YoY), and the FY2025 annual result was 0.06%, changed N/A from the prior year.
• Return on Sales came in at 0.04% for Q2 2023 at Mesoblast, up from 0.1% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.04% in Q2 2023 to a low of 0.28% in Q1 2019.
• The 5-year median for Return on Sales is 0.11% (2021), against an average of 0.11%.
• Peak annual rise in Return on Sales reached 19 bps in 2020, while the deepest fall reached 16 bps in 2020.
• Mesoblast's Return on Sales stood at 0.15% in 2019, then rose by 23 bps to 0.11% in 2020, then increased by 4 bps to 0.11% in 2021, then fell by 13 bps to 0.12% in 2022, then jumped by 133 bps to 0.04% in 2023.
• The last three Return on Sales figures came in at 0.04% (Q2 2023), 0.1% (Q1 2023), and 0.12% (Q4 2022), per Business Quant data.